
Mettler-Toledo International MTD
$ 1 051.07
0.88%
Quarterly report 2026-Q1
added 05-08-2026
Country |
|
IPO year |
1997 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
20.6 M |
Market Cap[1] |
$ 21.7 B |
EBITDA (LTM) |
$ 51.2 M |
P/E (LTM) |
30.75 |
P/S (LTM) |
6.03 |
EPS (LTM) |
36.57 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Co-Diagnostics
CODX
|
$ 1.32 | -19.18 % | $ 1.76 M | Nasdaq Capital Market | ||
|
Agilent Technologies
A
|
$ 112.44 | -0.71 % | $ 34.2 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 19.2 | 1.69 % | $ 557 M | Nasdaq Global Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 15.88 | -1.91 % | $ 480 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 140.85 | -1.67 % | $ 22.4 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.8 | - | $ 7.96 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.88 | -2.98 % | $ 1.06 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 94.55 | -2.2 % | $ 6.38 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 419.78 | 0.15 % | $ 12.1 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Myriad Genetics
MYGN
|
$ 3.65 | 0.69 % | $ 338 M | Nasdaq Global Select Market,SPB | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
NeoGenomics
NEO
|
$ 8.32 | -0.54 % | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.64 | -1.53 % | $ 417 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 188.14 | -4.45 % | $ 18.5 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 155.97 | -1.98 % | $ 7.73 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 25.36 | -0.55 % | $ 24 B | NYSE | ||
|
Guardant Health
GH
|
$ 93.95 | -4.77 % | $ 11.8 B | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 6.56 | -2.24 % | $ 585 M | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 5.71 | -1.89 % | $ 238 M | NYSE American | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 118.48 | 1.19 % | $ 9.77 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.98 | -0.02 % | $ 2.69 B | Nasdaq Capital Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biomerica
BMRA
|
$ 2.36 | -2.07 % | $ 5.42 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 252.76 | -0.5 % | $ 21 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
- | - | $ 167 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.56 | -3.75 % | $ 201 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 134.53 | -0.14 % | $ 6.29 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 48.6 | -8.22 % | $ 2.91 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 8.32 | -1.25 % | $ 1.8 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 187.2 | -0.39 % | $ 20.8 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.